NIH-funded research R03 grant

Annotating brain tumor and birth defect genetic drivers

Official title: Annotating the phenotypes of variants driving embryonal brain tumors and birth defects

Funded at University of California, San Francisco · NIH-11295247 · Data updated 2026-11-12

Researchers are studying how genetic differences that cause birth defects may also drive embryonal brain tumors, with the goal of clearer DNA clues for kids.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$328,000
NIH project number1R03CA309623-01
Project IDNIH-11295247 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are children and young patients whose birth defects or brain tumors have associated genetic data available in the Kids First Data Resource Center.

Less likely to help

Patients without the relevant genetic data or those outside the pediatric age range may not directly benefit.

What this research studies

This project looks at how shared genetic variants influence brain tumors in children with birth defects, using patient-derived brain tissue data. It will map which cells carry these driver variants and how they change gene activity and epigenetic marks. The team will annotate known and new driver variants and compare their patterns in tumor samples and congenital disease contexts. The work builds on existing pediatric data resources to connect genetics with cellular behavior, aiming for better diagnostics and future precision therapies.

Why it matters

Potential benefit: If successful, this work could improve genetic testing and guide targeted treatment strategies for children affected by both birth defects and embryonal brain tumors.

How similar studies have gone: Preliminary data and related studies have shown that shared variants can influence tumor biology and development, supporting the plausibility of this approach.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Diaz, Aaron Antonio — University of California, San Francisco
  • Study coordinator: Diaz, Aaron Antonio

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.